INR 241.75
(1.64%)
Year | Eps | Eps Growth |
---|---|---|
2023 | 5.89 INR | 809.64% |
2022 | -0.83 INR | -111.29% |
2021 | 7.35 INR | -0.54% |
2020 | 7.39 INR | 98.12% |
2019 | 3.73 INR | -21.14% |
2018 | 4.73 INR | 26.13% |
2017 | 3.75 INR | 11.28% |
2016 | 3.37 INR | -30.23% |
2015 | 4.83 INR | 16.11% |
2014 | 4.16 INR | 80.09% |
2013 | 2.31 INR | -8.7% |
2012 | 2.53 INR | 2200.0% |
2011 | 0.11 INR | -86.9% |
2010 | 0.84 INR | 250.0% |
2009 | 0.24 INR | -61.9% |
2008 | 0.63 INR | -76.84% |
2007 | 2.72 INR | -7.8% |
2006 | 2.95 INR | 41.83% |
2005 | 2.08 INR | 0.97% |
2004 | 2.06 INR | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q1 | 1.95 INR | -4.41% |
2023 Q3 | 1.36 INR | -2.16% |
2023 FY | - INR | 809.64% |
2023 Q1 | 1.10 INR | 50.68% |
2023 Q2 | 1.39 INR | 26.36% |
2023 Q4 | 2.04 INR | 50.0% |
2022 Q1 | -1.51 INR | -298.68% |
2022 Q3 | 0.44 INR | 283.33% |
2022 Q4 | 0.73 INR | 65.91% |
2022 Q2 | -0.24 INR | 84.11% |
2022 FY | - INR | -111.29% |
2021 FY | - INR | -0.54% |
2021 Q2 | 2.72 INR | -2.16% |
2021 Q1 | 2.78 INR | 1.46% |
2021 Q3 | 1.07 INR | -60.66% |
2021 Q4 | 0.76 INR | -28.97% |
2020 Q1 | 0.83 INR | 9.21% |
2020 Q2 | 1.30 INR | 56.63% |
2020 FY | - INR | 98.12% |
2020 Q4 | 2.74 INR | 8.3% |
2020 Q3 | 2.53 INR | 94.62% |
2019 Q4 | 0.76 INR | -15.56% |
2019 Q1 | 0.92 INR | -42.14% |
2019 Q2 | 1.17 INR | 27.17% |
2019 Q3 | 0.90 INR | -23.08% |
2019 FY | - INR | -21.14% |
2018 FY | - INR | 26.13% |
2018 Q3 | 1.11 INR | -6.72% |
2018 Q2 | 1.19 INR | 40.0% |
2018 Q1 | 0.85 INR | 0.0% |
2018 Q4 | 1.59 INR | 43.24% |
2017 FY | - INR | 11.28% |
2016 Q2 | 1.34 INR | 24.07% |
2016 Q1 | 1.08 INR | -25.0% |
2016 FY | - INR | -30.23% |
2015 Q2 | 1.24 INR | 45.88% |
2015 Q3 | 1.30 INR | 4.84% |
2015 Q4 | 1.44 INR | 10.77% |
2015 FY | - INR | 16.11% |
2015 Q1 | 0.85 INR | -30.89% |
2014 Q1 | 0.96 INR | -26.15% |
2014 FY | - INR | 80.09% |
2014 Q4 | 1.23 INR | -10.22% |
2014 Q3 | 1.37 INR | 124.59% |
2014 Q2 | 0.61 INR | -36.46% |
2013 Q3 | 0.99 INR | 65.0% |
2013 Q4 | 1.30 INR | 31.31% |
2013 FY | - INR | -8.7% |
2013 Q2 | 0.60 INR | 246.34% |
2013 Q1 | -0.41 INR | -105.85% |
2012 FY | - INR | 2200.0% |
2012 Q2 | -1.35 INR | -335.48% |
2012 Q1 | -0.31 INR | 8.82% |
2012 Q3 | -1.73 INR | -28.15% |
2012 Q4 | 7.01 INR | 505.2% |
2011 FY | - INR | -86.9% |
2011 Q4 | -0.34 INR | -383.33% |
2011 Q3 | 0.12 INR | 0.0% |
2010 FY | - INR | 250.0% |
2009 FY | - INR | -61.9% |
2008 FY | - INR | -76.84% |
2007 FY | - INR | -7.8% |
2006 FY | - INR | 41.83% |
2005 FY | - INR | 0.97% |
2004 FY | - INR | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Abbott India Limited | 565.30 INR | 98.958% |
Cipla Limited | 51.05 INR | 88.462% |
Gland Pharma Limited | 46.90 INR | 87.441% |
GlaxoSmithKline Pharmaceuticals Limited | 34.83 INR | 83.089% |
Kopran Limited | 10.57 INR | 44.276% |
Marksans Pharma Limited | 6.92 INR | 14.884% |
NGL Fine-Chem Limited | 66.88 INR | 91.193% |
Pfizer Limited | 120.51 INR | 95.112% |
Sanofi India Limited | 261.78 INR | 97.75% |
TTK Healthcare Limited | 44.47 INR | 86.755% |